Recent advances in amyotrophic lateral sclerosis

Current Opinion in Neurology

Volumn 13, Issue 4, 2000, Pages 397-405

  Al Chalabi, Ammar ^a   Leigh, P Nigel ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; NEUROFILAMENT PROTEIN; PERIPHERIN; RILUZOLE;

AMYOTROPHIC LATERAL SCLEROSIS; ASSISTED VENTILATION; GASTROSTOMY; GENE MUTATION; GENETIC LINKAGE; HUMAN; OXIDATIVE STRESS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; TRANSCRANIAL MAGNETIC STIMULATION;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; LINKAGE (GENETICS); MUTATION; NEUROLOGY; SUPEROXIDE DISMUTASE;

EID: 0033856830     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200008000-00006     Document Type: Review

References (82)

1. Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds
2. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients
3. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34
4. Autosomal dominant juvenile amyotrophic lateral sclerosis
5. Assignment of the disease locus for lethal congenital contracture syndrome to a restricted region of chromosome 9q34, by genome scan using five affected individuals
6. Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers
7. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis
8. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
9. Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: Homozygous NAIP deletion in a sporadic case
10. The relationship of spinal muscular atrophy to motor neuron disease: Investigation of SMN and NAIP gene deletions in sporadic and familial ALS
11. Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis
12. Mutations in the gene encoding human persyn are not associated with amyotrophic lateral sclerosis or familial Parkinson's disease
13. Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis
14. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite
15. Neurodegenerative disorders: The role of peroxynitrite
16. Neurofilament metabolism in sporadic amyotrophic lateral sclerosis
17. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis
18. Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis
19. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis
20. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis
21. Degeneration of NO-synthesizing cerebrocortical neurons in transgenic mice expressing mutated superoxide dismutase is not due to elevated nitric oxide levels
22. Administration of nitric oxide synthase inhibitors does not alter disease course of amyotrophic lateral sclerosis SOD1 mutant transgenic mice
23. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis
24. Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyotrophic lateral sclerosis
25. Prevention of mutant SOD1 motoneuron degeneration by copper chelators in vitro
26. Undetectable intracellular free copper: The requirement of a copper chaperone for superoxide dismutase
27. The copper chaperone CCS is abundant in neurons and astrocytes in human and rodent brain
28. Loss of in vitro metal ion binding specificity in mutant copper-zinc superoxide dismutases associated with familial amyotrophic lateral sclerosis
29. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons
30. Late onset death of motor neurons in mice overexpressing wild-type peripherin
31. Cyclin dependent kinase-5 (CDK-5) phosphorylates neurofilament heavy (NF-H) chain to generate epitopes for antibodies that label neurofilament accumulations in amyotrophic lateral sclerosis (ALS) and is present in affected motor neurones in ALS
32. Bcl-2 overexpression does not protect neurons from mutant neurofilament-mediated motor neuron degeneration
33. A receptor for advanced glycosylation endproducts (AGEs) is colocalized with neurofilament-bound AGEs and SOD1 in motoneurons of ALS: Immunohistochemical study
34. Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis
35. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis
36. Splicing of the glutamate transporter EAAT2: A candidate gene of amyotrophic lateral sclerosis
37. Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients
38. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter [published erratum appears in Nat Neurosci 1999; 9:848]
39. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis
40. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: Implications for the role of mitochondria in neuronal cell death
41. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
42. Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS
43. Detection of reverse transcriptase activity in the serum of patients with motor neurone disease
44. Incidence and prevalence of ALS in Ireland, 1995-1997: A population-based study
45. Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: A population-based case - Control study
46. Population-based case - Control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption
47. Population-based case - Control study of amyotrophic lateral sclerosis in western Washington State. II. Diet
48. Amyotrophic lateral sclerosis mimic syndromes: A population-based study
49. Flail arm syndrome: A distinctive variant of amyotrophic lateral sclerosis
50. Atypical form of amyotrophic lateral sclerosis
51. Brachial amyotrophic diplegia: A slowly progressive motor neuron disorder
52. Autosomal dominant familial spinal and bulbar muscular atrophy with gynaecomastia
53. A novel antineuronal antibody in a motor neuron syndrome associated with breast cancer
54. Dementia and aphasia in motor neuron disease: An underrecognised association?
55. Rapidly progressive aphasia and motor neuron disease: A clinical, radiological, and pathological study of an autopsy case with circumscribed lobar atrophy
56. Extrapyramidal involvement in amyotrophic lateral sclerosis: Backward falls and retropulsion
57. Sporadic amyotrophic lateral sclerosis with multiple system degeneration: A report of an autopsy case without respirator administration
58. Nigral degeneration in a case of amyotrophic lateral sclerosis: Evidence of Lewy body-like and skein-like inclusions in the pigmented neurons
59. Amyotrophic lateral sclerosis with supranuclear ophthalmoplegia and rigidity
60. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: A case - Control study. Caribbean Parkinsonism study group
61. Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease
62. Transcranial magnetic stimulation compared with upper motor neuron signs in patients with amyotrophic lateral sclerosis
63. Assessment of upper and lower motor neurons in Kennedy's disease: Implications for corticomotoneuronal PSTH studies
64. Pharmacologic reversal of cortical hyperexcitability in patients with ALS
65. Cortical muscle representation in amyotrophic lateral sclerosis patients: Changes with disease evolution
66. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: Subgroup analysis and follow-up measurements
67. Motor neuron diseases: Comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain
68. 1H-MRS evidence of neurodegeneration and excess glutamate+glutamine in ALS medulla
69. Diffusion tensor MRI assesses corticospinal tract damage in ALS
70. Sniff nasal pressure: A sensitive respiratory test to assess progression of amyotrophic lateral sclerosis
71. A prospective study of preferences and actual treatment choices in ALS
72. Correlates of suffering in amyotrophic lateral sclerosis
73. Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review): Report of the quality standards subcommittee of the American academy of neurology: ALS practice parameters task force
74. The ALS patient care database: Goals, design, and early results. ALS CARE study group
75. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: The ALSAQ-40
76. Bipap improves survival and rate of pulmonary function decline in patients with ALS
77. Nutritional status is a prognostic factor for survival in ALS patients
78. Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS percutaneous endoscopic gastrostomy study group
79. A controlled trial of recombinant methionyl human BDNF in ALS (phase III)
80. A randomized controlled trial of recombinant interferon beta-1a in ALS. Italian amyotrophic lateral sclerosis study group
81. The thought translation device: A neurophysiological approach to communication in total motor paralysis